Cardiovascular Business

Cardiovascular Business Cardiovascular Business is a news, business and technology source for cardiovascular medicine.

We focus on the business and economics behind the foremost clinical, interventional, surgical and information technologies.

01/07/2026

Based on feedback from the FDA, Aspire Biopharma plans on completing a multicenter clinical trial and then seeking regulatory approval for its new high-dose sublingual aspirin therapy.

The new RF ablation catheter from Stereotaxis moves through the use of computer-controlled magnets.
01/07/2026

The new RF ablation catheter from Stereotaxis moves through the use of computer-controlled magnets.

This new-look RF ablation catheter moves through the use of computer-controlled magnets, providing electrophysiologists with improved maneuverability and precision.

Fogarty created many inventions that fundamentally changed cardiac surgical practice, including the Fogarty balloon embo...
01/07/2026

Fogarty created many inventions that fundamentally changed cardiac surgical practice, including the Fogarty balloon embolectomy catheter, the Hancock Tissue Heart Valve and the first endovascular aortic stent graft.

Fogarty created many inventions that fundamentally changed cardiac surgical practice. He also received the Presidential Medal of Technology and Innovation from President Barack Obama in 2014.

VIDEO - Nick West, MD, Shockwave Medical CMO, explains how the company is innovating intravascular lithotripsy and build...
01/07/2026

VIDEO - Nick West, MD, Shockwave Medical CMO, explains how the company is innovating intravascular lithotripsy and building evidence from trials for a variety of calcified lesions, including valves.

Shockwave Medical

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe...
01/07/2026

Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now...
01/07/2026

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider.

According to Gore, the newly approved device was built with conformability, strength and fracture resistance in mind.
01/06/2026

According to Gore, the newly approved device was built with conformability, strength and fracture resistance in mind.

01/06/2026

President Trump, 79, says he is still in excellent health. He also has no intention of cutting down on the high dose of aspirin he takes each day.

01/06/2026

The incident was first reported in April 2025. This is a Class I recall, which means the FDA believes using these devices could result in serious injury or death.

Conformal Medical developed the device to help patients with nonvalvular atrial fibrillation reduce their risk of stroke...
01/06/2026

Conformal Medical developed the device to help patients with nonvalvular atrial fibrillation reduce their risk of stroke without the use of anticoagulants. The acquisition, once finalized, helps Gore expand its endovascular portfolio.

Conformal Medical developed its CLAAS technology to help patients with nonvalvular atrial fibrillation reduce their risk of stroke without the use of anticoagulants. Back in August, the company raised $32 million to help ramp up research on the device.

The Sapien M3 transcatheter mitral valve replacement system from Edwards Lifesciences is implanted using a transseptal a...
01/05/2026

The Sapien M3 transcatheter mitral valve replacement system from Edwards Lifesciences is implanted using a transseptal approach. The device previously received CE mark approval in 2025.

The Sapien M3 transcatheter mitral valve replacement system is implanted using a transseptal approach. The device previously received CE mark approval in 2025.

The pioneer in cardiac PET is now focused on expanding sales of its new cost-effective PET-CT system.
01/05/2026

The pioneer in cardiac PET is now focused on expanding sales of its new cost-effective PET-CT system.

The New York-based imaging company is now focused on expanding sales for the cost-effective PET-CT system it developed with Neusoft Medical Systems.

Address

Providence, RI

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Alerts

Be the first to know and let us send you an email when Cardiovascular Business posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cardiovascular Business:

Share